(Q29620605)
Statements
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) (English)
Thatcher N
Chang A
Parikh P
Rodrigues Pereira J
Ciuleanu T
von Pawel J
Thongprasert S
Tan EH
Pemberton K
Archer V
Carroll K
366
1527-37
9496